39 results on '"McKay, Kyla A."'
Search Results
2. Medication use and risk of amyotrophic lateral sclerosis—a systematic review
3. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis
4. Incidence rate and prevalence of pediatric‐onset multiple sclerosis in Sweden: A population‐based register study
5. Disclosing or concealing multiple sclerosis in the workplace : Two sides of the same coin-insights from a Swedish population-based survey
6. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada
7. Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
8. Socioeconomic status and quality of multiple sclerosis care in Sweden
9. Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.
10. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a populationbased study representing over half of Canada's population.
11. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada.
12. Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
13. Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
14. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
15. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada’s population
16. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada
17. Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
18. sj-docx-1-msj-10.1177_13524585231181578 – Supplemental material for Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
19. sj-docx-1-msj-10.1177_13524585231161492 – Supplemental material for Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
20. T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSIS
21. Association between brain volume and disability over time in multiple sclerosis
22. Pre-pregnancy maternal cardiovascular diseases and risk of offspring’s neurodevelopmental disorders: a population-based cohort study.
23. COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
24. T16. THE ASSOCIATION BETWEEN DEPRESSION POLYGENICITY AND DISEASE ACTIVITY AND DISABILITY WORSENING IN MULTIPLE SCLEROSIS
25. Polygenicity of Comorbid Depression in Multiple Sclerosis
26. COVID-19 clinical outcomes and DMT of MS patients and population-based controls
27. Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study.
28. sj-docx-1-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
29. Additional file 1 of Medication use and risk of amyotrophic lateral sclerosis—a systematic review
30. sj-docx-2-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
31. sj-docx-3-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
32. Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
33. Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
34. Administrative data for observational research in multiple sclerosis: Opportunities and challenges
35. Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.
36. Administrative data for observational research in multiple sclerosis: Opportunities and challenges.
37. Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County.
38. Comorbidities and their association with outcomes in the multiple sclerosis population: a rapid review
39. Disclosing or concealing multiple sclerosis in the workplace: two sides of the same coin-insights from a Swedish population-based survey.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.